Quarterly report pursuant to Section 13 or 15(d)

Consolidated Balance Sheets

v3.24.1.u1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2024
Dec. 31, 2023
Current assets:    
Cash and cash equivalents $ 191,882 $ 187,288
Short-term restricted cash 1,028 1,051
Accounts receivable, net 126,230 170,619
Inventory 96,125 99,908
Prepaid expenses and other current assets 29,414 29,159
Total current assets 444,679 488,025
Long-term restricted cash 20 17
Property and equipment, net 68,338 66,431
Leased right-of-use assets 27,468 31,264
Intangible assets, net 64,939 73,630
Goodwill 318,588 318,588
Deferred tax assets 72,176 69,493
Other long-term assets 34,417 32,809
Total assets 1,030,625 1,080,257
Current liabilities:    
Accounts payable 32,392 21,551
Accrued price protection liability 65,233 71,684
Accrued expenses and other current liabilities 98,132 98,468
Accrued compensation 28,097 30,426
Total current liabilities 223,854 222,129
Long-term lease liabilities 23,897 26,243
Long-term debt 122,529 122,375
Other long-term liabilities 22,362 23,245
Total liabilities 392,642 393,992
Commitments and contingencies
Stockholders’ equity:    
Preferred stock, $0.0001 par value; 25,000 shares authorized, no shares issued or outstanding 0 0
Common stock, $0.0001 par value; 550,000 shares authorized; 83,067 shares issued and outstanding at March 31, 2024 and 81,818 shares issued and outstanding December 31, 2023 8 8
Additional paid-in capital 834,384 808,575
Accumulated other comprehensive loss (5,573) (3,791)
Accumulated deficit (190,836) (118,527)
Total stockholders’ equity 637,983 686,265
Total liabilities and stockholders’ equity $ 1,030,625 $ 1,080,257